Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1236867
PUBLISHER: IMARC | PRODUCT CODE: 1236867
Diabetic Retinopathy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
PUBLISHED:
PAGES: 142 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global diabetic retinopathy market size reached US$ 7.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.8 Billion by 2028, exhibiting a growth rate (CAGR) of 6.1% during 2023-2028.
Diabetic retinopathy (DR) refers to the damage caused to the blood vessels in the retina by diabetes mellitus. This ailment is of two kinds, namely non-proliferative DR and proliferative or advanced DR. It is caused by fluctuations in the blood glucose levels resulting in an abnormal growth in the light-sensitive tissues present in the eye. The symptoms of DR include the visibility of dark spots or floating strings in the vision field, blurred or fluctuating vision, impaired color vision or loss of vision. It can be diagnosed through tests, such as fluorescein angiography and optical coherence tomography, and the treatment involves the use of intraocular steroid injection, laser treatment and vitrectomy.
The increasing prevalence of diabetes, along with the growing geriatric population across the globe, represent as the key factors driving the growth of the market. Furthermore, the rising incidence of blindness caused by DR is also providing a boost to the market growth. There is an increasing awareness among the masses regarding the available treatment alternatives and the benefits of early detection of DR. This has resulted in the widespread adoption of technologically advanced procedures and equipment, such as the improved ophthalmic diagnostic and surgical instruments. These procedures and equipment enable early detection and efficient treatment of the ailment with higher precision and minimal discomfort to the patient. Other factors, including the increasing healthcare expenditures, the implementation of favorable government policies to make advanced healthcare services available to the masses and extensive research and development (R&D) activities, are projected to drive the market further.
Key Market Segmentation:
- IMARC Group provides an analysis of the key trends in each sub-segment of the global diabetic retinopathy market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, treatment type and end-user.
Breakup by Type:
- Proliferative Diabetic Retinopathy
- Non-proliferative Retinopathy
Breakup by Treatment Type:
- Anti VEGF Drugs
- Steroid Implants
- Laser Surgeries
- Vitrectomy
Breakup by End-User:
- Hospitals and Pharmacies
- Eye Clinics
- Ambulatory Surgical Centres (ASCs)
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
- The competitive landscape of the industry has also been examined with some of the key players being Alimera Sciences, Allergan PLC, Ampio Pharmaceuticals, Bayer Healthcare, BCN Peptides, Genentech, Kowa Group, Novartis AG, Regeneron Pharmaceuticals Inc., Sirnaomics Inc., etc.
Key Questions Answered in This Report:
- How has the global diabetic retinopathy market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global diabetic retinopathy market?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the treatment type?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global diabetic retinopathy market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR1523A132_Report
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Diabetic Retinopathy Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Proliferative Diabetic Retinopathy
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Non-proliferative Retinopathy
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Treatment Type
- 7.1 Anti VEGF Drugs
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Steroid Implants
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Laser Surgeries
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Vitrectomy
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by End-User
- 8.1 Hospitals and Pharmacies
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Eye Clinics
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Ambulatory Surgical Centres (ASCs)
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Competitive Landscape
- 13.1 Market Structure
- 13.2 Key Players
- 13.3 Profiles of Key Players
- 13.3.1 Alimera Sciences
- 13.3.1.1 Company Overview
- 13.3.1.2 Product Portfolio
- 13.3.1.3 Financials
- 13.3.2 Allergan Plc
- 13.3.2.1 Company Overview
- 13.3.2.2 Product Portfolio
- 13.3.2.3 Financials
- 13.3.2.4 SWOT Analysis
- 13.3.3 Ampio Pharmaceuticals
- 13.3.3.1 Company Overview
- 13.3.3.2 Product Portfolio
- 13.3.4 Bayer Healthcare
- 13.3.4.1 Company Overview
- 13.3.4.2 Product Portfolio
- 13.3.4.3 Financials
- 13.3.4.4 SWOT Analysis
- 13.3.5 BCN Peptides
- 13.3.5.1 Company Overview
- 13.3.5.2 Product Portfolio
- 13.3.5.3 Financials
- 13.3.6 Genentech
- 13.3.6.1 Company Overview
- 13.3.6.2 Product Portfolio
- 13.3.6.3 SWOT Analysis
- 13.3.7 Kowa Group
- 13.3.7.1 Company Overview
- 13.3.7.2 Product Portfolio
- 13.3.8 Novartis AG
- 13.3.8.1 Company Overview
- 13.3.8.2 Product Portfolio
- 13.3.9 Regeneron Pharmaceuticals Inc.
- 13.3.9.1 Company Overview
- 13.3.9.2 Product Portfolio
- 13.3.9.3 Financials
- 13.3.9.4 SWOT Analysis
- 13.3.10 Sirnaomics Inc.
- 13.3.10.1 Company Overview
- 13.3.10.2 Product Portfolio
- 13.3.1 Alimera Sciences
Product Code: SR1523A132_Report
List of Figures
- Figure 1: Global: Diabetic Retinopathy Market: Major Drivers and Challenges
- Figure 2: Global: Diabetic Retinopathy Market: Sales Value (in Billion US$), 2017-2022
- Figure 3: Global: Diabetic Retinopathy Market: Breakup by Type (in %), 2022
- Figure 4: Global: Diabetic Retinopathy Market: Breakup by Treatment Type (in %), 2022
- Figure 5: Global: Diabetic Retinopathy Market: Breakup by End-User (in %), 2022
- Figure 6: Global: Diabetic Retinopathy Market: Breakup by Region (in %), 2022
- Figure 7: Global: Diabetic Retinopathy Market Forecast: Sales Value (in Billion US$), 2023-2028
- Figure 8: Global: Diabetic Retinopathy (Proliferative Diabetic Retinopathy) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 9: Global: Diabetic Retinopathy (Proliferative Diabetic Retinopathy) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 10: Global: Diabetic Retinopathy (Non-proliferative Retinopathy) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 11: Global: Diabetic Retinopathy (Non-proliferative Retinopathy) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 12: Global: Diabetic Retinopathy (Anti VEGF Drugs) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 13: Global: Diabetic Retinopathy (Anti VEGF Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 14: Global: Diabetic Retinopathy (Steroid Implants) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 15: Global: Diabetic Retinopathy (Steroid Implants) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 16: Global: Diabetic Retinopathy (Laser Surgeries) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 17: Global: Diabetic Retinopathy (Laser Surgeries) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 18: Global: Diabetic Retinopathy (Vitrectomy) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 19: Global: Diabetic Retinopathy (Vitrectomy) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 20: Global: Diabetic Retinopathy (Hospitals and Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 21: Global: Diabetic Retinopathy (Hospitals and Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 22: Global: Diabetic Retinopathy (Eye Clinics) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 23: Global: Diabetic Retinopathy (Eye Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 24: Global: Diabetic Retinopathy (Ambulatory Surgical Centres-ASCs) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 25: Global: Diabetic Retinopathy (Ambulatory Surgical Centres-ASCs) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 26: Global: Diabetic Retinopathy (Others) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 27: Global: Diabetic Retinopathy (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 28: North America: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
- Figure 29: North America: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 30: United States: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
- Figure 31: United States: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 32: Canada: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
- Figure 33: Canada: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 34: Asia Pacific: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
- Figure 35: Asia Pacific: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 36: China: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
- Figure 37: China: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 38: Japan: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
- Figure 39: Japan: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 40: India: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
- Figure 41: India: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 42: South Korea: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
- Figure 43: South Korea: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 44: Australia: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
- Figure 45: Australia: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 46: Indonesia: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
- Figure 47: Indonesia: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 48: Others: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
- Figure 49: Others: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 50: Europe: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
- Figure 51: Europe: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 52: Germany: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
- Figure 53: Germany: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 54: France: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
- Figure 55: France: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 56: United Kingdom: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
- Figure 57: United Kingdom: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 58: Italy: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
- Figure 59: Italy: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 60: Spain: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
- Figure 61: Spain: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 62: Russia: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
- Figure 63: Russia: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 64: Others: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
- Figure 65: Others: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 66: Latin America: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
- Figure 67: Latin America: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 68: Brazil: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
- Figure 69: Brazil: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 70: Mexico: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
- Figure 71: Mexico: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 72: Others: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
- Figure 73: Others: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 74: Middle East and Africa: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
- Figure 75: Middle East and Africa: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 76: Global: Diabetic Retinopathy Industry: SWOT Analysis
- Figure 77: Global: Diabetic Retinopathy Industry: Value Chain Analysis
- Figure 78: Global: Diabetic Retinopathy Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Diabetic Retinopathy Market: Key Industry Highlights, 2022 and 2028
- Table 2: Global: Diabetic Retinopathy Market Forecast: Breakup by Type (in Million US$), 2023-2028
- Table 3: Global: Diabetic Retinopathy Market Forecast: Breakup by Treatment Type (in Million US$), 2023-2028
- Table 4: Global: Diabetic Retinopathy Market Forecast: Breakup by End-User (in Million US$), 2023-2028
- Table 5: Global: Diabetic Retinopathy Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 6: Global: Diabetic Retinopathy Market: Competitive Structure
- Table 7: Global: Diabetic Retinopathy Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.